<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36195985</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1930-739X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Obesity (Silver Spring, Md.)</Title><ISOAbbreviation>Obesity (Silver Spring)</ISOAbbreviation></Journal><ArticleTitle>Association of BMI with general health, working capacity recovered, and post-acute sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>43</StartPage><EndPage>48</EndPage><MedlinePgn>43-48</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/oby.23611</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study was to determine the risk of post-acute sequelae of COVID-19 associated with the continuous spectrum of BMI.</AbstractText><AbstractText Label="METHODS">Epidemiology of Long COVID (EPILOC) is a population-based study conducted in Baden-W&#xfc;rttemberg (Germany), including subjects aged 18 to 65&#x2009;years who tested positive for SARS-CoV-2 between October 2020 and April 2021. Eligible subjects answered a standardized questionnaire, including sociodemographic characteristics, lifestyle factors, and the presence of specific symptoms. Participants assessed their current general health recovery and working capacity compared with the pre-infection situation and provided their body height and weight. Generalized additive models were used to assess the association of BMI with general health recovered, working capacity recovered, and prevalence of fatigue, cognitive impairment, and chest symptoms.</AbstractText><AbstractText Label="RESULTS">The analyses included 11,296 individuals (41% male), with a mean age of 44.0 (SD 13.7) years. Best general health recovery was observed at BMI of 22.1 (95% CI: 21.0-27.0) kg/m<sup>2</sup> in men and BMI of 21.6 (95% CI: 20.3-23.1) kg/m<sup>2</sup> in women. In addition, we found that increasing BMI was consistently associated with post-COVID fatigue, neurocognitive impairment, and chest symptoms.</AbstractText><AbstractText Label="CONCLUSIONS">High BMI contributes to impaired recovery after SARS-CoV-2 infection; however, a low BMI is associated with impaired recovery as well.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>Raphael S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0003-4310-9500</Identifier><AffiliationInfo><Affiliation>Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieters</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Immunodeficiency, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brockmann</LastName><ForeName>Stefan O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Health Protection, Infection Control and Epidemiology, Baden-Wuerttemberg Federal State Health Office, Ministry of Social Affairs, Health and Integration Stuttgart, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;pel</LastName><ForeName>Siri</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine I, University Hospital T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kindle</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Immunodeficiency, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merle</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinacker</LastName><ForeName>J&#xfc;rgen M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Sports and Rehabilitation Medicine, Department of Medicine, Ulm University Hospital, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kern</LastName><ForeName>Winfried V</ForeName><Initials>WV</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine II, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothenbacher</LastName><ForeName>Dietrich</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EPILOC Phase 1 Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obesity (Silver Spring)</MedlineTA><NlmUniqueID>101264860</NlmUniqueID><ISSNLinking>1930-7381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declared no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36195985</ArticleId><ArticleId IdType="pmc">PMC9874798</ArticleId><ArticleId IdType="doi">10.1002/oby.23611</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich H&#x2010;G, et al; EPILOC Phase 1 Study Group. Post&#x2010;acute&#xa0;sequelae&#xa0;of&#xa0;covid&#x2010;19 six to 12 months after infection: population based study. BMJ. 2022;379:e071050. doi:10.1136/bmj-2022-071050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, et al. A nationwide questionnaire study of post&#x2010;acute symptoms and health problems after SARS&#x2010;CoV&#x2010;2 infection in Denmark. Nat Commun 2022;13:4213. doi:10.1038/s41467&#x2010;022&#x2010;31897&#x2010;x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID&#x2010;19 in The Netherlands: an observational cohort study. Lancet 2022;400:452&#x2010;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60&#x2009;years is a risk factor for COVID&#x2010;19 hospital admission. Clin Infect Dis 2020;71:896&#x2010;897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184372</ArticleId><ArticleId IdType="pubmed">32271368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergens M&#x2010;P, Bell M, Haglund P, et al. Risk factors for COVID&#x2010;19&#x2010;related death, hospitalization and intensive care: a population&#x2010;wide study of all inhabitants in Stockholm. Eur J Epidemiol 2022;37:157&#x2010;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791671</ArticleId><ArticleId IdType="pubmed">35083602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates T, Zaccardi F, Islam N, et al.; ISARIC4C investigators . Obesity, ethnicity, and risk of critical care, mechanical ventilation, and mortality in patients admitted to hospital with COVID&#x2010;19: analysis of the ISARIC CCP&#x2010;UK cohort. Obesity (Silver Spring) 2021;29:1223&#x2010;1230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251439</ArticleId><ArticleId IdType="pubmed">33755331</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau&#x2010;Hyam M, et al. Persistent COVID&#x2010;19 symptoms in a community study of 606, 434 people in England. Nat Commun. 2022;13:1957. doi:10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosen SH, Jensen B&#x2010;EO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross&#x2010;sectional study from 50,402 COVID&#x2010;19 patients. Infection. 2022;50:1165&#x2010;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="pubmed">35355237</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F, Tadini E, Munting A, Regina J, et al. Post&#x2010;COVID&#x2010;19 syndrome in outpatients: a cohort study. J Gen Intern Med. 2022;37:1943&#x2010;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep 2021;11:16144. doi:10.1038/s41598&#x2010;021&#x2010;95565&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID&#x2010;19&#x2010;related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death&#x2014;United States, March&#x2013;December 2020. MMWR Morb Mortal Wkly Rep 2021;70:355&#x2010;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7951819</ArticleId><ArticleId IdType="pubmed">33705371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang IS, Kong KA. Body mass index and severity/fatality from coronavirus disease 2019: a nationwide epidemiological study in Korea. PloS One 2021;16:e0253640. doi:10.1371/journal.pone.0253640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8219144</ArticleId><ArticleId IdType="pubmed">34157043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebener M, Hasselhorn HM. Validation of short measures of work ability for research and employee surveys. Int J Environ Res Public Health 2019;16:3386. doi:10.3390/ijerph16183386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765804</ArticleId><ArticleId IdType="pubmed">31547466</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>